Lifeline Biotechnologies, Inc. (OTCPK:LLBO) will look for acquisitions. The intended result of these activities is to accelerate CI's drive to possible significant value via generation of revenue by the end of 2019 or early 2020, through sales directly to physician clinics, leading to a possible merger or acquisition potentially some time in 2020.